✦ LIBER ✦

Sensitizing glioma cells to cisplatin by abrogating the p53 response with antisense oligonucleotides

✍ Scribed by Datta, Kamal; Shah, Preeti; Srivastava, Tapasya; Mathur, Srinivas G; Chattopadhyay, Parthaprasad; Sinha, Subrata

Book ID: 110019129
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 261 KB
Volume: 11
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700724

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53 regulation of leukemia cells with th

P53 regulation of leukemia cells with the blockage of MDM2 by antisense oligonucleotides

✍ Minghao Fang; Xuemei Ji; Yi Tang; Wenli Liu 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 Chinese ⚖ 223 KB

Downregulation of Hus1 by antisense olig

Downregulation of Hus1 by antisense oligonucleotides enhances the sensitivity of human lung carcinoma cells to cisplatin

✍ Bernd Kinzel; Jonathan Hall; Francois Natt; Jan Weiler; Dalia Cohen 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (